Stopping weight-loss medication after weight-loss surgery
Part of Hormones & metabolism clinical trials.
This study looks at two ways to stop taking semaglutide (a weight-loss medication), either by lowering the dose gradually or stopping all at once, for people who have used it after weight-loss surgery. It aims to see which way helps keep weight off more stably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had weight-loss (bariatric) surgery of any type
- You have been taking semaglutide (e.g., Wegovy) at 1.7 mg or more for at least 6 months
- You were prescribed semaglutide because you regained weight or did not lose enough after your surgery
- Your weight has been stable (within about 3%) for the last 12 weeks
- You and your doctor have decided it is time to stop taking semaglutide
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting semaglutide (a weekly injection that helps with weight loss) soon after surgery works better than waiting to see if you need it. If you have not lost enough weight one year after your surgery, this trial may help you decide the best time to start this medication.
This study tests a weekly injection of semaglutide (a medication that helps control appetite) in people who have regained weight after weight-loss surgery. The goal is to see if it can help them lose weight again and keep it off.
This trial tests whether taking a weekly injection called semaglutide (a type of medicine used for weight loss) for about 16 weeks before weight-loss surgery can help people with a very high BMI prepare for surgery. It may reduce liver fat and make surgery safer, which could lead to better outcomes.
This study tests whether taking semaglutide (a once-weekly injection that helps control appetite and blood sugar) before and after a second weight-loss surgery can help people who regained weight after an initial sleeve gastrectomy. The goal is to see if the medicine improves weight-loss outcomes compared to surgery alone.
This study looks at what happens to your body and weight when you stop taking semaglutide (Wegovy/Ozempic) after losing at least 10% of your starting weight. The goal is to understand how your metabolism and heart health change once the medication is paused.
This study tests whether slowly reducing the dose of the weight-loss medication semaglutide can help keep weight off after losing at least 10% of body weight. It compares two ways of tapering the dose to see which works better for maintaining weight loss.
Hear when a new Morbid Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.